A Report of special importance for leprosy is that of the First Meeting of THELEP, where pages 8 and 9 deal with drug regimens to be tested, and Appendix 5.13 and 5.14 with the management of reversal reactions and of erythema nodosum leprosum.
We continue to draw attention to the development and progress of this momentous Special Programme for obvious reasons, and take this opportunity of reminding readers of Leprosy Review that by writing fo rmally to Hilary Boardman, Secretary, Special Programme for Research and Training in Tropical Diseases, WHO, 1211 Geneva 27, Switzerland, bona fide applicants may obtain documentation on the Programme, and also have a regular Newsletter posted to them.
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